Christos K. Kontos
Freising, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.
Journal: Nature communications
Published: January 24, 2024
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation.
Journal: Cellular and molecular life sciences : CMLS
Published: January 28, 2022
A MIF-Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2.
Journal: Chembiochem : a European journal of chemical biology
Published: August 16, 2020
Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.
Journal: Nature communications
Published: December 02, 2019
Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs.
Journal: The Journal of biological chemistry
Published: June 07, 2019
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Journal: Thrombosis and haemostasis
Published: February 05, 2019
Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
Journal: Scientific reports
Published: October 03, 2017
22-gauge core vs 22-gauge aspiration needle for endoscopic ultrasound-guided sampling of abdominal masses.
Journal: World journal of gastroenterology
Published: June 25, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026